Precipio, Inc.

PRPO Healthcare Diagnostics & Research

Precipio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $24.0 million, up 29.8% from fiscal 2024. In the quarter to June 2026, revenue grew 24.2%, EPS fell 340.0%, free cash flow grew 79.6% and total debt rose 47.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

21.38 1.16 −5.15%
Market cap
$40.4M
P/E
0.0×
Fwd P/E
15.4×
Dividend yield
—
F-score
6/9
Altman Z
−2.40
Beneish M
−1.62
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.28 1.53 1.73 1.63
P/FCF ratio
49.46 102.74 80.32 56.09
P/Operating CF
2,913.11 100.78 696.52 67.05
P/B ratio
2.12 2.53 3.15 3.00
EV/Sales
1.22 1.46 1.65 1.55
EV/EBITDA
0.00 63.40 1,709.78 142.41
EV/FCF
47.05 97.67 77.02 53.43
Current Ratio
1.27 1.61 1.56 1.77
Net Debt/EBITDA
(3.77) (1.79) 1.89 16.15
Debt/Equity
0.06 0.06 0.05 0.07
Earnings Yield
(4.61%) (1.09%) (1.88%) (2.58%)
Free Cash Flow Yield
2.02% 0.97% 1.25% 1.78%
Free Cash Flow per Share
(0.03) 0.18 0.01 0.30
Book value per Share
8.40 9.07 7.95 8.26
Free Cash Flow
(0.04) 0.29 0.01 0.53
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates